Arthur Caplan of the School of Medicine says, “The FDA should keep a ‘close eye’ on commercial gene tests.”
Health & Medicine
PHILADELPHIA –- An international collaboration led by chemists and engineers from the University of Pennsylvania has prepared a library of synthetic biomaterials that mimic cellular membranes and that show promise in targeted delivery of cancer drugs, gene therapy, proteins, imaging and diagnostic agents and cosmetics safely to the body in the emerging field called nanomedicine.
The study appears in the current issue of the journal Science.
Sarah Lyon of the School of Medicine is cited for research on how insurance affects medical care in intensive-care units.
Neill Epperson of the School of Medicine and Center for Women's Behavioral Wellness says a child’s development is unique and should not be compared to other children’s.
Arthur Caplan of the School of Medicine says cosmetic-treatment advertising presents a conflict of interest.
Aura Obando, a graduating student in the School of Medicine, is profiled for her international medical work.